Dextrose Monohydrate 10% Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Dextrose Monohydrate 10% Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Mar 1, 2022. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-824-74
Dosage Form
Injection
Presentation
Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-74)
Initial Posting
Mar 1, 2022

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.